Superluminal Medicines Launches With $33 Million Seed Round To Fuel Its Drug Discovery Engine And Pipeline Of Small Molecule Therapeutics
Amount Raised
$33 Million
Round Type
Seed
BostonBiotechnologyHealth CareDescription
Superluminal Medicines Inc., a generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created, today announced the closing of a $33 million funding round. The investment was led by RA Capital Management with significant participation from Insight Partners and NVIDIA. Gaingels also joined in the financing.
Quick answer
Superluminal Medicines raised $33 Million in a Seed round, dated August 28, 2023. Superluminal Medicines is based in Boston, Massachusetts, United States.
- How much did Superluminal Medicines raise?
- Superluminal Medicines raised $33 Million in a Seed round on August 28, 2023.
- What does Superluminal Medicines do?
- Superluminal Medicines is a Boston-based generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created.
- Where is Superluminal Medicines based and how big is it?
- Superluminal Medicines is based in Boston, Massachusetts, United States. Fundz records about 29 employees.
- Who are the decision-makers at Superluminal Medicines?
- Fundz holds 2 contacts at Superluminal Medicines. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Superluminal Medicines that raised within 45 days of this round, from Fundz verified event records.
- Streamex Corp. raised $861K (Seed) on October 12, 2023.
- RDS raised an undisclosed amount (Seed) on October 12, 2023.
- Trait Biosciences Inc. raised an undisclosed amount (Funding Round) on October 11, 2023.
- Specific Biologics raised an undisclosed amount on October 10, 2023.
- Optimize Systems raised $18M (Series B) on October 10, 2023.
- Pixelgen Technologies raised an undisclosed amount (Series A) on October 9, 2023.
Who to call at Superluminal Medicines, and when
A new round usually means Superluminal Medicines is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Superluminal Medicines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Superluminal Medicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Superluminal Medicines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Superluminal Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Superluminal Medicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.